Taro Pharmaceutical Industries is a multinational, science-based pharmaceutical company. Co. develops, manufactures and markets prescription and over-the-counter pharmaceutical products mainly in the U.S., Canada and Israel. Co.'s main focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. Co. manufactures finished dosage form pharmaceutical products for sale in Israel and for export; and produces active pharmaceutical ingredients used in the manufacture of finished dosage form pharmaceutical products. We show 12 historical shares outstanding datapoints in our TARO shares outstanding history coverage, used to compute TARO market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing TARO market cap history over the course of time is important for investors
interested in comparing TARO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of TARO versus a peer is one thing; comparing
TARO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like TARO can fluctuate over the course of history.
With this page we aim to empower investors researching TARO by allowing them to research the TARO market cap history. |
Free TARO Email Alerts:
Video: The Importance of Market Cap
